ClinicalTrials.Veeva

Menu

The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal Cancer

U

University of Indonesia (UI)

Status

Unknown

Conditions

Colorectal Cancer

Treatments

Diagnostic Test: Score assessment
Diagnostic Test: Fecal sampling
Diagnostic Test: Blood sampling

Study type

Observational

Funder types

Other

Identifiers

NCT04011969
19-05-0528

Details and patient eligibility

About

This study aims to investigate the role of gut microbiome pattern and inflammation marker NF-ҡB in young-onset colorectal cancer

Enrollment

150 estimated patients

Sex

All

Ages

35+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age ≥ 35 years old
  2. Suspected with colorectal cancer and undergoing a colonoscopy procedure
  3. No history of colorectal cancer treatment

Exclusion criteria

  1. Unwilling to provide fecal and blood sample
  2. Incomplete colonoscopy procedure due to any reasons

Trial design

150 participants in 1 patient group

Colorectal cancer suspects
Description:
Patients suspected with colorectal cancer who come to our hospital to conduct colonoscopy procedure will be recruited for this study and will undergo a series of examinations.
Treatment:
Diagnostic Test: Fecal sampling
Diagnostic Test: Score assessment
Diagnostic Test: Blood sampling

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Murdani Abdullah

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems